Olink Holding AB engages in the provision of accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. It operates through the following segments: Kit, Service, and All Other Segments. The company was founded on December 13, 2018, and is headquartered in Uppsala, Sweden.